Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2012

Open Access 01-12-2012 | Editorial

Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action

Authors: Jean Carlet, Vincent Jarlier, Stephan Harbarth, Andreas Voss, Herman Goossens, Didier Pittet, the Participants of the 3rd World Healthcare-Associated Infections Forum

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2012

Login to get access

Abstract

Resistance to antibiotics has increased dramatically over the past few years and has now reached a level that places future patients in real danger. Microorganisms such as Escherichia coli and Klebsiella pneumoniae, which are commensals and pathogens for humans and animals, have become increasingly resistant to third-generation cephalosporins. Moreover, in certain countries, they are also resistant to carbapenems and therefore susceptible only to tigecycline and colistin. Resistance is primarily attributed to the production of beta-lactamase genes located on mobile genetic elements, which facilitate their transfer between different species. In some rare cases, Gram-negative rods are resistant to virtually all known antibiotics. The causes are numerous, but the role of the overuse of antibiotics in both humans and animals is essential, as well as the transmission of these bacteria in both the hospital and the community, notably via the food chain, contaminated hands, and between animals and humans. In addition, there are very few new antibiotics in the pipeline, particularly for Gram-negative bacilli. The situation is slightly better for Gram-positive cocci as some potent and novel antibiotics have been made available in recent years. A strong and coordinated international programme is urgently needed. To meet this challenge, 70 internationally recognized experts met for a two-day meeting in June 2011 in Annecy (France) and endorsed a global call to action ("The Pensières Antibiotic Resistance Call to Action"). Bundles of measures that must be implemented simultaneously and worldwide are presented in this document. In particular, antibiotics, which represent a treasure for humanity, must be protected and considered as a special class of drugs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Carlet J, Collignon P, Goldmann D, Goosens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N'Doye B, Pittet D, Richtmann R, Seto WH, van der Meer JW, Voss A: Society's failure to protect a precious resource: antibiotics. Lancet. 2011, 378: 369-371. 10.1016/S0140-6736(11)60401-7.CrossRefPubMed Carlet J, Collignon P, Goldmann D, Goosens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N'Doye B, Pittet D, Richtmann R, Seto WH, van der Meer JW, Voss A: Society's failure to protect a precious resource: antibiotics. Lancet. 2011, 378: 369-371. 10.1016/S0140-6736(11)60401-7.CrossRefPubMed
2.
go back to reference Buchholz U, Bernard H, Werber D, Böhmer MM, Remschmidt C, Wilking H, Deleré Y, van der Heiden M, Adlhoch C, Dreesman J, Ehlers J, Ethelberg S, Faber M, Frank C, Fricke G, Greiner M, Höhle M, Ivarsson S, Jark U, Kirchner M, Koch J, Krause G, Luber P, Rosner B, Stark K, Kühne M: German outbreak of Escherichia coli 0104:H4 associated with sprouts. N Engl J Med. 2011, 365: 1763-1770. 10.1056/NEJMoa1106482.CrossRefPubMed Buchholz U, Bernard H, Werber D, Böhmer MM, Remschmidt C, Wilking H, Deleré Y, van der Heiden M, Adlhoch C, Dreesman J, Ehlers J, Ethelberg S, Faber M, Frank C, Fricke G, Greiner M, Höhle M, Ivarsson S, Jark U, Kirchner M, Koch J, Krause G, Luber P, Rosner B, Stark K, Kühne M: German outbreak of Escherichia coli 0104:H4 associated with sprouts. N Engl J Med. 2011, 365: 1763-1770. 10.1056/NEJMoa1106482.CrossRefPubMed
3.
go back to reference Hughes JM: Preserving the lifesaving power of antimicrobial agents. JAMA. 2011, 305: 1027-1028. 10.1001/jama.2011.279.CrossRefPubMed Hughes JM: Preserving the lifesaving power of antimicrobial agents. JAMA. 2011, 305: 1027-1028. 10.1001/jama.2011.279.CrossRefPubMed
4.
go back to reference Piddock LJ: The crisis of no new antibiotics-what is the way forward?. Lancet Infect Dis. 2011, Piddock LJ: The crisis of no new antibiotics-what is the way forward?. Lancet Infect Dis. 2011,
5.
go back to reference Carlet J, Mainardi JL: Antibacterial agents: back to the future. Can we live with only colistin, co-trimoxazole, and fosfomycin. Clin Microbiol Infect. 2012, Carlet J, Mainardi JL: Antibacterial agents: back to the future. Can we live with only colistin, co-trimoxazole, and fosfomycin. Clin Microbiol Infect. 2012,
7.
go back to reference Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gür D, Jarlier V, Kahlmeter G, Jarlier V, Kahlmeter G, Monen J, Monnet DL, Rossollini GM, Suetens C, Weist K, Heuer O, EARS-Net Participants (Disease Specific Contact Points for AMR): Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formely EARSS), 2002 to 2009. Euro Surveill. 2011, 16: pii:19819 Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gür D, Jarlier V, Kahlmeter G, Jarlier V, Kahlmeter G, Monen J, Monnet DL, Rossollini GM, Suetens C, Weist K, Heuer O, EARS-Net Participants (Disease Specific Contact Points for AMR): Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formely EARSS), 2002 to 2009. Euro Surveill. 2011, 16: pii:19819
8.
go back to reference Meir S, Weber R, Zbinden R, Ruef C, Hasse B: Extended- spectrum beta-lactamases-producing Gram negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection. 2011, Meir S, Weber R, Zbinden R, Ruef C, Hasse B: Extended- spectrum beta-lactamases-producing Gram negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection. 2011,
9.
go back to reference Hawser SP, Bouchillon SK, Lascols C, Hackel M, Hoban DJ, Badal R, Canton R: Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum beta-lactamases occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009). Clin Microbiol Infect. 2011, Hawser SP, Bouchillon SK, Lascols C, Hackel M, Hoban DJ, Badal R, Canton R: Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum beta-lactamases occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009). Clin Microbiol Infect. 2011,
10.
go back to reference Gupta N, Limbago BM, Patel JB, Kallen AJ: Carbapenem-resistant enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011, 53: 60-67. 10.1093/cid/cir202.CrossRefPubMed Gupta N, Limbago BM, Patel JB, Kallen AJ: Carbapenem-resistant enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011, 53: 60-67. 10.1093/cid/cir202.CrossRefPubMed
11.
go back to reference Naas T, Cozon G, Gaillot O, Courcol R, Nordmann P: When carbapenem-hydrolizing ss-lactamase KPC meets Escherichia coli ST-131 in France. Antimicrob Agents Chemother. 2011, Naas T, Cozon G, Gaillot O, Courcol R, Nordmann P: When carbapenem-hydrolizing ss-lactamase KPC meets Escherichia coli ST-131 in France. Antimicrob Agents Chemother. 2011,
12.
go back to reference Kumarasamy KK, Toleman MA, Walsh TR: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010, 10: 597-602. 10.1016/S1473-3099(10)70143-2.PubMedCentralCrossRefPubMed Kumarasamy KK, Toleman MA, Walsh TR: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010, 10: 597-602. 10.1016/S1473-3099(10)70143-2.PubMedCentralCrossRefPubMed
13.
go back to reference Van Gastel E, Costers M, Peetermans WE, Struelens MJ, Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee: Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother. 2010, 65: 576-580. 10.1093/jac/dkp470.CrossRefPubMed Van Gastel E, Costers M, Peetermans WE, Struelens MJ, Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee: Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother. 2010, 65: 576-580. 10.1093/jac/dkp470.CrossRefPubMed
14.
go back to reference Wilson J, Elgohari S, Livermore DM, Cookson B, Johnson A, Lamagni T, Chronias A, Sheridan E: Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect. 2011, 17: 451-458. 10.1111/j.1469-0691.2010.03262.x.CrossRefPubMed Wilson J, Elgohari S, Livermore DM, Cookson B, Johnson A, Lamagni T, Chronias A, Sheridan E: Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect. 2011, 17: 451-458. 10.1111/j.1469-0691.2010.03262.x.CrossRefPubMed
15.
go back to reference Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlete G, Buu-Hoi A, Carlet J, Decré D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brücker G, Régnier B, Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France: Curbing methicillin Staphylococcus aureus in 38 French hospitals through a 15-year institutional program. Arch Intern Med. 2010, 170: 552-559. 10.1001/archinternmed.2010.32.CrossRefPubMed Jarlier V, Trystram D, Brun-Buisson C, Fournier S, Carbonne A, Marty L, Andremont A, Arlete G, Buu-Hoi A, Carlet J, Decré D, Gottot S, Gutmann L, Joly-Guillou ML, Legrand P, Nicolas-Chanoine MH, Soussy CJ, Wolf M, Lucet JC, Aggoune M, Brücker G, Régnier B, Collégiale de Bactériologie-Virologie-Hygiène des Hôpitaux Universitaires de l'Ile de France: Curbing methicillin Staphylococcus aureus in 38 French hospitals through a 15-year institutional program. Arch Intern Med. 2010, 170: 552-559. 10.1001/archinternmed.2010.32.CrossRefPubMed
16.
go back to reference Couet W, Gregoire N, Marchand SH, Momoz O: Colistin pharmacokinetics: the fog is lifting. Clin Microbiol Infect. 2012, Couet W, Gregoire N, Marchand SH, Momoz O: Colistin pharmacokinetics: the fog is lifting. Clin Microbiol Infect. 2012,
19.
go back to reference Roberts R, Hota B, Ahmad I, Scott RD, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA: Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009, 49: 1175-1184. 10.1086/605630.CrossRefPubMed Roberts R, Hota B, Ahmad I, Scott RD, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA: Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009, 49: 1175-1184. 10.1086/605630.CrossRefPubMed
20.
go back to reference De Kracker MEA, Davey PG, Grundmann H, on behalf of the BURDEN group: Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011, 8: e1001104-10.1371/journal.pmed.1001104.CrossRef De Kracker MEA, Davey PG, Grundmann H, on behalf of the BURDEN group: Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011, 8: e1001104-10.1371/journal.pmed.1001104.CrossRef
21.
go back to reference Allegranzi B, Storr J, Dziekan G, Leotsakos A, Donaldson L, Pittet D: The first global patient safety challenge "Clean care is safer care": from launch to current progress and achievements. J Hosp Infect. 2007, 65 (Suppl 2): 115-123.CrossRefPubMed Allegranzi B, Storr J, Dziekan G, Leotsakos A, Donaldson L, Pittet D: The first global patient safety challenge "Clean care is safer care": from launch to current progress and achievements. J Hosp Infect. 2007, 65 (Suppl 2): 115-123.CrossRefPubMed
22.
go back to reference Swaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, Shalit I, Carmeli Y, Israel Carbapenem-Resistant Enterobacteriaceae Working Group: Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumonia in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis. 2011, 52: 848-855. 10.1093/cid/cir025.CrossRef Swaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, Shalit I, Carmeli Y, Israel Carbapenem-Resistant Enterobacteriaceae Working Group: Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumonia in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis. 2011, 52: 848-855. 10.1093/cid/cir025.CrossRef
23.
go back to reference Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM, Infectious Diseases Society of America; Society for Healthcare Epidemiology of America: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007, 44: 159-157. 10.1086/510393.CrossRefPubMed Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM, Infectious Diseases Society of America; Society for Healthcare Epidemiology of America: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007, 44: 159-157. 10.1086/510393.CrossRefPubMed
24.
go back to reference Sabuncu E, David J, Bemede-Bauduin C, Pépin S, Leroy M, Boëlle PX, Watier L, Guillemot D: Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 2009, 6: e1000008.CrossRef Sabuncu E, David J, Bemede-Bauduin C, Pépin S, Leroy M, Boëlle PX, Watier L, Guillemot D: Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 2009, 6: e1000008.CrossRef
26.
go back to reference Campos J, Ferech M, Lazaro E, de Abajo F, Oteo J, Stephens P, Goossens H: Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother. 2007, 60: 698-701. 10.1093/jac/dkm248.CrossRefPubMed Campos J, Ferech M, Lazaro E, de Abajo F, Oteo J, Stephens P, Goossens H: Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother. 2007, 60: 698-701. 10.1093/jac/dkm248.CrossRefPubMed
27.
go back to reference Mainous AG, Everett CJ, Post RE, Diaz VA, Hueston WJ: Availability of antibiotics for purchase without a prescription on the internet. Ann Fam Med. 2009, 7: 431-435. 10.1370/afm.999.PubMedCentralCrossRefPubMed Mainous AG, Everett CJ, Post RE, Diaz VA, Hueston WJ: Availability of antibiotics for purchase without a prescription on the internet. Ann Fam Med. 2009, 7: 431-435. 10.1370/afm.999.PubMedCentralCrossRefPubMed
29.
go back to reference European Centre for Disease Prevention and Control (ECDC), European Food Safety Authority (EFSA), European Medicines Agency (EMEA) and the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR): Joint Opinion on antimicrobial resistance (AMR) focused on zoonotic infections. EFSA J. 2009, 7: 1372-[http://www.efsa.europa.eu/it/efsajournal/doc/1372.pdf] European Centre for Disease Prevention and Control (ECDC), European Food Safety Authority (EFSA), European Medicines Agency (EMEA) and the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR): Joint Opinion on antimicrobial resistance (AMR) focused on zoonotic infections. EFSA J. 2009, 7: 1372-[http://​www.​efsa.​europa.​eu/​it/​efsajournal/​doc/​1372.​pdf]
33.
go back to reference Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J: Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009, 48: 1-12. 10.1086/595011.CrossRefPubMed Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J: Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009, 48: 1-12. 10.1086/595011.CrossRefPubMed
35.
go back to reference Huttner B, Goossens H, Verheij T, Harbarth S, CHAMP Consortium: Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010, 10: 17-31. 10.1016/S1473-3099(09)70305-6.CrossRefPubMed Huttner B, Goossens H, Verheij T, Harbarth S, CHAMP Consortium: Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010, 10: 17-31. 10.1016/S1473-3099(09)70305-6.CrossRefPubMed
36.
go back to reference Huttner B, Harbarth S: "Antibiotics are not automatic anymore" - The French national campaign to cut antibiotic overuse. PLoS Med. 2009, 6: e1000080-10.1371/journal.pmed.1000080.PubMedCentralCrossRefPubMed Huttner B, Harbarth S: "Antibiotics are not automatic anymore" - The French national campaign to cut antibiotic overuse. PLoS Med. 2009, 6: e1000080-10.1371/journal.pmed.1000080.PubMedCentralCrossRefPubMed
37.
go back to reference Carlet J, Astagneau P, Brun-Buisson C, Coignard B, Salomon V, Tran B, Desenclos JC, Jarlier V, Schlemmer B, Parneix P, Regnier B, Fabry J, French National Program for Prevention of Healthcare-Associated Infections and Antimicrobial Resistance: French national program for prevention of health-care-associated infections and antimicrobial resistance.1992-2008: positive trends but perseverance needed. Infect Control Hosp Infect. 2009, 30: 737-745. 10.1086/598682.CrossRef Carlet J, Astagneau P, Brun-Buisson C, Coignard B, Salomon V, Tran B, Desenclos JC, Jarlier V, Schlemmer B, Parneix P, Regnier B, Fabry J, French National Program for Prevention of Healthcare-Associated Infections and Antimicrobial Resistance: French national program for prevention of health-care-associated infections and antimicrobial resistance.1992-2008: positive trends but perseverance needed. Infect Control Hosp Infect. 2009, 30: 737-745. 10.1086/598682.CrossRef
40.
go back to reference Powers JH: Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs. Clin Infect Dis. 2007, 45 (Suppl 2): S135-S162. Powers JH: Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs. Clin Infect Dis. 2007, 45 (Suppl 2): S135-S162.
41.
go back to reference Carlet J, the World Alliance Against Multiple-Resistant Bacteria: Halte à la résistance: sauvons les antibiotiques. Med Mal Inf. 2011, 41: 351-352. 10.1016/j.medmal.2011.06.003.CrossRef Carlet J, the World Alliance Against Multiple-Resistant Bacteria: Halte à la résistance: sauvons les antibiotiques. Med Mal Inf. 2011, 41: 351-352. 10.1016/j.medmal.2011.06.003.CrossRef
42.
43.
go back to reference Neugenauer EA: To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock. Crit Care Med. 2007, 35: 2855-2858. 10.1097/01.CCM.0000295277.26957.65.CrossRef Neugenauer EA: To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock. Crit Care Med. 2007, 35: 2855-2858. 10.1097/01.CCM.0000295277.26957.65.CrossRef
44.
go back to reference Eckert R: Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol. 2011, 6: 635-651. 10.2217/fmb.11.27.CrossRefPubMed Eckert R: Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol. 2011, 6: 635-651. 10.2217/fmb.11.27.CrossRefPubMed
45.
go back to reference Hanion GW: Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents. 2007, 30: 118-128. Hanion GW: Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents. 2007, 30: 118-128.
46.
go back to reference Burt S: Essential oils: their antibacterial properties and potential applications in foods. A review. Int J Food Microbiol. 2004, 94: 223-253. 10.1016/j.ijfoodmicro.2004.03.022.CrossRefPubMed Burt S: Essential oils: their antibacterial properties and potential applications in foods. A review. Int J Food Microbiol. 2004, 94: 223-253. 10.1016/j.ijfoodmicro.2004.03.022.CrossRefPubMed
47.
go back to reference Spellberg B, Daum R: Development of a vaccine against Staphylococcus aureus. Semin Immunopathol. 2011, Spellberg B, Daum R: Development of a vaccine against Staphylococcus aureus. Semin Immunopathol. 2011,
48.
go back to reference Finkelstein JA, Huang SS, Kleinman K, Rifas-Shiman SL, Stille CJ, Daniel J, Schiff N, Steingard R, Soumerai SB, Ross-Degnan D, Goldmann D, Platt R: Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics. 2008, 121: e15-23. 10.1542/peds.2007-0819.CrossRefPubMed Finkelstein JA, Huang SS, Kleinman K, Rifas-Shiman SL, Stille CJ, Daniel J, Schiff N, Steingard R, Soumerai SB, Ross-Degnan D, Goldmann D, Platt R: Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics. 2008, 121: e15-23. 10.1542/peds.2007-0819.CrossRefPubMed
49.
go back to reference Regev-Yochay G, Raz M, Dagan R, Roizin H, Morag B, Hetman S, Ringel S, Ben-Israel N, Varon M, Somekh E, Rubinstein E: Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription study. Clin Infect Dis. 2011, 53: 33-41. 10.1093/cid/cir272.CrossRefPubMed Regev-Yochay G, Raz M, Dagan R, Roizin H, Morag B, Hetman S, Ringel S, Ben-Israel N, Varon M, Somekh E, Rubinstein E: Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription study. Clin Infect Dis. 2011, 53: 33-41. 10.1093/cid/cir272.CrossRefPubMed
50.
go back to reference Bavestrello L, Cabello A, Casanova D: Impact of regulatory measures in the trends of community consumption of antibiotics in Chile. Rev Med Chil. 2002, 130: 1265-1272.CrossRefPubMed Bavestrello L, Cabello A, Casanova D: Impact of regulatory measures in the trends of community consumption of antibiotics in Chile. Rev Med Chil. 2002, 130: 1265-1272.CrossRefPubMed
51.
go back to reference Jarlier V, Carlet J, McGowan J, Goossens H, Voss A, Harbarth S, Pittet D, the participants of the 3rd World Health-care Associated Infections Forum: Priority actions to fight antibiotic resistance: results of an international meeting. ARIC. 2012, 1: xxxxx Jarlier V, Carlet J, McGowan J, Goossens H, Voss A, Harbarth S, Pittet D, the participants of the 3rd World Health-care Associated Infections Forum: Priority actions to fight antibiotic resistance: results of an international meeting. ARIC. 2012, 1: xxxxx
52.
go back to reference Read RC, Cornaglia G, Kahlmeter G, European Society of Clinical Microbiology and Infectious Diseases Professional Affairs Workshop Group: Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe. Lancet Infect Dis. 2011, 11: 408-415. 10.1016/S1473-3099(10)70294-2.CrossRefPubMed Read RC, Cornaglia G, Kahlmeter G, European Society of Clinical Microbiology and Infectious Diseases Professional Affairs Workshop Group: Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe. Lancet Infect Dis. 2011, 11: 408-415. 10.1016/S1473-3099(10)70294-2.CrossRefPubMed
53.
go back to reference Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA, STAR* ICU Trial Investigators: Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011, 364: 1407-1418. 10.1056/NEJMoa1000373.PubMedCentralCrossRefPubMed Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA, STAR* ICU Trial Investigators: Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011, 364: 1407-1418. 10.1056/NEJMoa1000373.PubMedCentralCrossRefPubMed
54.
go back to reference Longtin Y, Sax H, Allegranzi B, Schneider F, Pittet D: Videos in clinical medicine. Hand hygiene. N Engl J Med. 2011, 364: e 24.CrossRef Longtin Y, Sax H, Allegranzi B, Schneider F, Pittet D: Videos in clinical medicine. Hand hygiene. N Engl J Med. 2011, 364: e 24.CrossRef
55.
go back to reference Antimicrobial stewardship for the community hospital: practical tools and techniques for implementation. Clin Infect Dis. 2011, 53 (Suppl 1): S1-S30. Antimicrobial stewardship for the community hospital: practical tools and techniques for implementation. Clin Infect Dis. 2011, 53 (Suppl 1): S1-S30.
56.
go back to reference Zarb J, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H, ESAC-3 Hospital Care Subproject Group: Identification of targets for quality improvement in antibiotic prescribing: the web-based ESAC Point Prevalence Study 2009. Antimicrob Chemother. 2010, 65: 443-449. Zarb J, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H, ESAC-3 Hospital Care Subproject Group: Identification of targets for quality improvement in antibiotic prescribing: the web-based ESAC Point Prevalence Study 2009. Antimicrob Chemother. 2010, 65: 443-449.
58.
go back to reference Madurell J, Balagué M, Gomez M, Cots JM, Llor C: Impact of rapid antigen detection testing on antibiotic prescription in acute pharyngitis in adults. FARINGOCAT STUDY: a multicentric randomized controlled trial. BMC Fam Pract. 2010, 11: 25-29.PubMedCentralCrossRefPubMed Madurell J, Balagué M, Gomez M, Cots JM, Llor C: Impact of rapid antigen detection testing on antibiotic prescription in acute pharyngitis in adults. FARINGOCAT STUDY: a multicentric randomized controlled trial. BMC Fam Pract. 2010, 11: 25-29.PubMedCentralCrossRefPubMed
59.
go back to reference Burkhardt O, Ewig S, Giesdorf S, Giersdorf S, Harmann O, Wegscheider K, Hummers-Pradier E, Welte T: Procalcotonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010, 36: 601-607. 10.1183/09031936.00163309.CrossRefPubMed Burkhardt O, Ewig S, Giesdorf S, Giersdorf S, Harmann O, Wegscheider K, Hummers-Pradier E, Welte T: Procalcotonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J. 2010, 36: 601-607. 10.1183/09031936.00163309.CrossRefPubMed
60.
go back to reference Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B: Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infec Ther. 2010, 8: 575-587. 10.1586/eri.10.25.CrossRef Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B: Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infec Ther. 2010, 8: 575-587. 10.1586/eri.10.25.CrossRef
61.
go back to reference Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M, PRORATA trial group: Use of procalcitonin to reduce patient's exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomized controlled trial. Lancet. 2010, 375: 463-474. 10.1016/S0140-6736(09)61879-1.CrossRefPubMed Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M, PRORATA trial group: Use of procalcitonin to reduce patient's exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomized controlled trial. Lancet. 2010, 375: 463-474. 10.1016/S0140-6736(09)61879-1.CrossRefPubMed
62.
go back to reference Infectious Diseases Society of America: The 10 × '20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis. 2010, 50: 1081-1083.CrossRef Infectious Diseases Society of America: The 10 × '20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis. 2010, 50: 1081-1083.CrossRef
63.
go back to reference Outterson K, Samora JB, Keller-Cuda K: Will longer antimicrobial patents improve public health?. Lancet Infect Dis. 2007, 7: 559-566. 10.1016/S1473-3099(07)70188-3.CrossRefPubMed Outterson K, Samora JB, Keller-Cuda K: Will longer antimicrobial patents improve public health?. Lancet Infect Dis. 2007, 7: 559-566. 10.1016/S1473-3099(07)70188-3.CrossRefPubMed
64.
go back to reference Lecky DM, McNulty CA, Adriaenssens N, Koprivová Herotová T, Holt J, Touboul P, Merakou K, Koncan R, Olczak-Pienkowska A, Avô AB, Campos J, Farrell D, Kostkova P, Weinberg J, e-Bug Working Group: What are school children in Europe being taught about hygiene and antibiotic use?. J Antimicrob Chemother. 2011, 66 (Suppl 5): v13-21.CrossRefPubMed Lecky DM, McNulty CA, Adriaenssens N, Koprivová Herotová T, Holt J, Touboul P, Merakou K, Koncan R, Olczak-Pienkowska A, Avô AB, Campos J, Farrell D, Kostkova P, Weinberg J, e-Bug Working Group: What are school children in Europe being taught about hygiene and antibiotic use?. J Antimicrob Chemother. 2011, 66 (Suppl 5): v13-21.CrossRefPubMed
65.
go back to reference De Quincey E, Kostkova P, Jawaheer G, Farrell D, McNulty CA, Weiberg J, e-Bug Working Group: Evaluating the on-line activity of users of the e-Bug website. J Antimicrob Chemother. 2011, 66 (Suppl 5): v45-49.CrossRefPubMed De Quincey E, Kostkova P, Jawaheer G, Farrell D, McNulty CA, Weiberg J, e-Bug Working Group: Evaluating the on-line activity of users of the e-Bug website. J Antimicrob Chemother. 2011, 66 (Suppl 5): v45-49.CrossRefPubMed
66.
go back to reference Grave K, Torren-Edo J, Mackay D: Comparison of the sales of veterinary antibacterial agents between 10 European countries. J Antimicrob Chemother. 2010, 65: 2037-2040. 10.1093/jac/dkq247.CrossRefPubMed Grave K, Torren-Edo J, Mackay D: Comparison of the sales of veterinary antibacterial agents between 10 European countries. J Antimicrob Chemother. 2010, 65: 2037-2040. 10.1093/jac/dkq247.CrossRefPubMed
68.
go back to reference Freire-Moran L, Aronsson B, Manz C, Gyssens IC, Monnet D, Cars O, ECDC-EMA Working Group: Critical shortage of new antibiotics in development against multidrug-resistant bacteria - time to react is now. Drug Resist Updat. 2011, 14: 118-124. 10.1016/j.drup.2011.02.003.CrossRefPubMed Freire-Moran L, Aronsson B, Manz C, Gyssens IC, Monnet D, Cars O, ECDC-EMA Working Group: Critical shortage of new antibiotics in development against multidrug-resistant bacteria - time to react is now. Drug Resist Updat. 2011, 14: 118-124. 10.1016/j.drup.2011.02.003.CrossRefPubMed
69.
go back to reference Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, Mobashery S, Piddock LJ, Projan S, Thomas CM, Tomasz A, Tulkens PM, Walsh TR, Watson JD, Witkowski J, Witte W, Wright G, Yeh P, Zgurskaya HI: Tackling antibiotic resistance. Nat Rev Microbiol. 2011, 9: 894-898. 10.1038/nrmicro2693.PubMedCentralCrossRefPubMed Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, Mobashery S, Piddock LJ, Projan S, Thomas CM, Tomasz A, Tulkens PM, Walsh TR, Watson JD, Witkowski J, Witte W, Wright G, Yeh P, Zgurskaya HI: Tackling antibiotic resistance. Nat Rev Microbiol. 2011, 9: 894-898. 10.1038/nrmicro2693.PubMedCentralCrossRefPubMed
70.
go back to reference Okeke IN, Peeling RW, Goossens H, Auckenthaler R, Olmsted SS, de Lavison JF, Zimmer BL, Perkins MD, Nordqvist K: Diagnostics as essential tools for containing antibiotic resistance. Drug Resist Updat. 2011, 14: 95-106. 10.1016/j.drup.2011.02.002.CrossRefPubMed Okeke IN, Peeling RW, Goossens H, Auckenthaler R, Olmsted SS, de Lavison JF, Zimmer BL, Perkins MD, Nordqvist K: Diagnostics as essential tools for containing antibiotic resistance. Drug Resist Updat. 2011, 14: 95-106. 10.1016/j.drup.2011.02.002.CrossRefPubMed
71.
go back to reference Hulscher ME, Grol RP, van der Meer JW: Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010, 10: 167-175. 10.1016/S1473-3099(10)70027-X.CrossRefPubMed Hulscher ME, Grol RP, van der Meer JW: Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010, 10: 167-175. 10.1016/S1473-3099(10)70027-X.CrossRefPubMed
72.
go back to reference Vanden Eng J, Marcus R, Hadler JL, Imhoff B, Vugia DJ, Cieslak PR, Zell E, Deneen V, McCombs KG, Zansky SM, Hawkins MA, Besser RE: Consumer attitudes and use of antibiotics. Emerg Infect Dis. 2003, 9: 1128-1135.PubMedCentralCrossRefPubMed Vanden Eng J, Marcus R, Hadler JL, Imhoff B, Vugia DJ, Cieslak PR, Zell E, Deneen V, McCombs KG, Zansky SM, Hawkins MA, Besser RE: Consumer attitudes and use of antibiotics. Emerg Infect Dis. 2003, 9: 1128-1135.PubMedCentralCrossRefPubMed
73.
go back to reference Harbarth S, Albrich W, Brun-Buisson C: Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis. 2002, 8: 1460-1467.PubMedCentralCrossRefPubMed Harbarth S, Albrich W, Brun-Buisson C: Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis. 2002, 8: 1460-1467.PubMedCentralCrossRefPubMed
74.
go back to reference Powers JH: Antimicrobial drug development - the past, the present, the future. Clin Microbiol Infect. 2004, 10 (Suppl 4): 23-31.CrossRefPubMed Powers JH: Antimicrobial drug development - the past, the present, the future. Clin Microbiol Infect. 2004, 10 (Suppl 4): 23-31.CrossRefPubMed
75.
go back to reference The McDonnell Norms Group: Antibiotic overuse: the influence of social norms. J Am Coll Surg. 2008, 207: 265-275.CrossRef The McDonnell Norms Group: Antibiotic overuse: the influence of social norms. J Am Coll Surg. 2008, 207: 265-275.CrossRef
76.
go back to reference Richman PB, Garra G, Eskin B, Nashed AH, Cody R: Oral antibiotic use without consulting a physician: a survey of ED patients. Am J Emerg Med. 2001, 19: 57-60. 10.1053/ajem.2001.20035.CrossRefPubMed Richman PB, Garra G, Eskin B, Nashed AH, Cody R: Oral antibiotic use without consulting a physician: a survey of ED patients. Am J Emerg Med. 2001, 19: 57-60. 10.1053/ajem.2001.20035.CrossRefPubMed
77.
go back to reference Grigoryan L, Burgerhof JG, Degener JE, Deschepper R, Lundborg CS, Monnet DL, Scicluna EA, Birkin J, Haaijer-Ruskamp FM, Self-Medication with Antibiotics and Resistance (SAR) Consortium: Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. J Antimicrob Chemother. 2008, 61: 1172-1179. 10.1093/jac/dkn054.CrossRefPubMed Grigoryan L, Burgerhof JG, Degener JE, Deschepper R, Lundborg CS, Monnet DL, Scicluna EA, Birkin J, Haaijer-Ruskamp FM, Self-Medication with Antibiotics and Resistance (SAR) Consortium: Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. J Antimicrob Chemother. 2008, 61: 1172-1179. 10.1093/jac/dkn054.CrossRefPubMed
78.
go back to reference Väänänen MH, Pietilä K, Airaksinen M: Self-medication with antibiotics-does it really happen in Europe?. Health Policy. 2006, 77: 166-171. 10.1016/j.healthpol.2005.07.001.CrossRefPubMed Väänänen MH, Pietilä K, Airaksinen M: Self-medication with antibiotics-does it really happen in Europe?. Health Policy. 2006, 77: 166-171. 10.1016/j.healthpol.2005.07.001.CrossRefPubMed
82.
go back to reference Alliance for the Prudent Use of Antibiotics (APUA): Situation analysis of antibiotic misuse in US food animals: APUA background paper. APUA Newsletter. 2010, 28: 1-7. Alliance for the Prudent Use of Antibiotics (APUA): Situation analysis of antibiotic misuse in US food animals: APUA background paper. APUA Newsletter. 2010, 28: 1-7.
83.
go back to reference Alliance for the Prudent Use of Antibiotics (APUA): Consequences of antibiotic misuse in food animals and interventions: APUA background paper. APUA Newsletter. 2010, 28: 7-13. Alliance for the Prudent Use of Antibiotics (APUA): Consequences of antibiotic misuse in food animals and interventions: APUA background paper. APUA Newsletter. 2010, 28: 7-13.
87.
go back to reference Cassone M, Giordano A: Resistance genes travelling the microbial internet: down the drain, up the food chain?. Expert Rev Anti Infect Ther. 2009, 7: 637-639. 10.1586/eri.09.50.CrossRefPubMed Cassone M, Giordano A: Resistance genes travelling the microbial internet: down the drain, up the food chain?. Expert Rev Anti Infect Ther. 2009, 7: 637-639. 10.1586/eri.09.50.CrossRefPubMed
88.
go back to reference Knapp CW, Dolfing J, Ehlert PA, Graham DW: Evidence of increasing antibiotic resistance gene abundance in archived soils since 1940. Environ Sci Technol. 2010, 44: 580-587. 10.1021/es901221x.CrossRefPubMed Knapp CW, Dolfing J, Ehlert PA, Graham DW: Evidence of increasing antibiotic resistance gene abundance in archived soils since 1940. Environ Sci Technol. 2010, 44: 580-587. 10.1021/es901221x.CrossRefPubMed
89.
go back to reference Van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma N, Beaujean D, Voss A, Kluytmans J: Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis. 2007, 13: 1834-1839.PubMedCentralCrossRefPubMed Van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma N, Beaujean D, Voss A, Kluytmans J: Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis. 2007, 13: 1834-1839.PubMedCentralCrossRefPubMed
90.
go back to reference Smith TC, Male MJ, Harper AL: Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in Midwestern US swine and swine workers. PLoS One. 2009, 4: e4258-10.1371/journal.pone.0004258.PubMedCentralCrossRefPubMed Smith TC, Male MJ, Harper AL: Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in Midwestern US swine and swine workers. PLoS One. 2009, 4: e4258-10.1371/journal.pone.0004258.PubMedCentralCrossRefPubMed
91.
go back to reference Soavi L, Stellini R, Signorini L, Antonini B, Pedroni P, Zanetti L, Milanesi B, Pantosti A, Matteelli A, Pan A, Carosi G: Methicillin-resistant Staphylococcus aureus ST398, Italy. Emerg Infect Dis. 2010, 16: 346-348.PubMedCentralCrossRefPubMed Soavi L, Stellini R, Signorini L, Antonini B, Pedroni P, Zanetti L, Milanesi B, Pantosti A, Matteelli A, Pan A, Carosi G: Methicillin-resistant Staphylococcus aureus ST398, Italy. Emerg Infect Dis. 2010, 16: 346-348.PubMedCentralCrossRefPubMed
92.
go back to reference Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, Heck M, Savelkoul P, Vandenbroucke-Grauls C, van der Zwaluw K, Huijsdens X, Kluytmans J: Extended-spectrum beta-lactamases genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis. 2011, 17: 1216-1222. 10.3201/eid1707.110209.PubMedCentralCrossRefPubMed Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, Heck M, Savelkoul P, Vandenbroucke-Grauls C, van der Zwaluw K, Huijsdens X, Kluytmans J: Extended-spectrum beta-lactamases genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis. 2011, 17: 1216-1222. 10.3201/eid1707.110209.PubMedCentralCrossRefPubMed
93.
go back to reference Graveland H, Wagenaar JA, Heesterbeek H, Mevius D, van Duijkeren E, Heederik D: Methicillin-resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene. PLoS One. 2010, 8: e10990.CrossRef Graveland H, Wagenaar JA, Heesterbeek H, Mevius D, van Duijkeren E, Heederik D: Methicillin-resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene. PLoS One. 2010, 8: e10990.CrossRef
96.
97.
go back to reference Aarestrup FM, Hendriksen RS, Lockett J, Gay K, Teates K, McDermott PF, White DG, Hasman H, Sorensen G, Bangtrakulnonth A, Pornreongwong S, Pulsrikarn C, Angulo FJ, Gerner-Smidt P: International spread of multidrug-resistant Salmonella Schwarzengrund in food products. Emerg Infect Dis. 2007, 13: 726-731.PubMedCentralCrossRefPubMed Aarestrup FM, Hendriksen RS, Lockett J, Gay K, Teates K, McDermott PF, White DG, Hasman H, Sorensen G, Bangtrakulnonth A, Pornreongwong S, Pulsrikarn C, Angulo FJ, Gerner-Smidt P: International spread of multidrug-resistant Salmonella Schwarzengrund in food products. Emerg Infect Dis. 2007, 13: 726-731.PubMedCentralCrossRefPubMed
98.
go back to reference Nisha AR: Antibiotic residues - a global health hazard. Vet World. 2008, 1: 375-377.CrossRef Nisha AR: Antibiotic residues - a global health hazard. Vet World. 2008, 1: 375-377.CrossRef
99.
go back to reference Power E: Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect. 2006, 12 (Suppl 5): 25-34.CrossRefPubMed Power E: Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect. 2006, 12 (Suppl 5): 25-34.CrossRefPubMed
100.
go back to reference Powers JH: Recommendations for improving the design, conduct and analysis of clinical trials in hospital acquired pneumonia and ventilator-associated pneumonia. Clin Infect Dis. 2010, 51 (Suppl 1): S18-S28.PubMedCentralCrossRefPubMed Powers JH: Recommendations for improving the design, conduct and analysis of clinical trials in hospital acquired pneumonia and ventilator-associated pneumonia. Clin Infect Dis. 2010, 51 (Suppl 1): S18-S28.PubMedCentralCrossRefPubMed
Metadata
Title
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action
Authors
Jean Carlet
Vincent Jarlier
Stephan Harbarth
Andreas Voss
Herman Goossens
Didier Pittet
the Participants of the 3rd World Healthcare-Associated Infections Forum
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2012
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/2047-2994-1-11

Other articles of this Issue 1/2012

Antimicrobial Resistance & Infection Control 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.